Comparison of Myocardial Infarction Patients Who Were Prescribed a Novel Antiplatelet Agent or Clopidogrel
NCT05599152 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3000
Last updated 2022-10-31
Summary
Myocardial infarction is defined according to icd-10 using the data base of South korea National Health Insurance Corporation, where personal identification information has already been removed, and detailed results are derived for each drug category.
Conditions
Sponsors & Collaborators
-
Chong Kun Dang Pharmaceutical
collaborator INDUSTRY -
Chan Joon Kim
lead OTHER
Principal Investigators
-
Chan Joon Kim · The Catholic University of Korea, Uijeongbu ST. Mary's Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-05-21
- Primary Completion
- 2022-11-30
- Completion
- 2022-11-30
Countries
- South Korea
Study Locations
More Related Trials
-
SMart Angioplasty Research Team: CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 3
NCT04418479 ·Status: COMPLETED ·Phase: PHASE4
-
Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- EXtended Antiplatelet Monotherapy (HOST-EXAM)
NCT02044250 ·Status: COMPLETED ·Phase: PHASE4
-
REsistance to Aspirin and Clopidogrel in acuTe Myocardial Infarction
NCT01381185 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Low-Dose, Standard-Dose Ticagrelor and Clopidogrel for Inhibition of Platelet Reactivity in Patients With Acute Coronary Syndromes
NCT02319941 ·Status: COMPLETED ·Phase: PHASE2
-
Platelet Reactivity And Clinical ThrombotIC Events Study
NCT03525145 ·Status: UNKNOWN
-
Ticagrelor Versus Clopidogrel for CMD in Patients With AMI: A Retrospective Study Based on the Angio-IMR
NCT05978726 ·Status: COMPLETED
-
Implementation of a Personalized Medicine (Pharmacogenomics) Service in a Community Pharmacy
NCT01495845 ·Status: COMPLETED ·Phase: PHASE1
-
Genetic Polymorphism Associated With Coronary Heart Disease Susceptibility and Variability of Clopidogrel Response
NCT03373552 ·Status: ACTIVE_NOT_RECRUITING
-
Anticoagulation in Stent Intervention
NCT01141153 ·Status: UNKNOWN ·Phase: PHASE4
-
Ticagrelor and Clopidogrel on Platelet Aggregation in Clopidogrel Resistance's Patients With CHD
NCT03614832 ·Status: UNKNOWN ·Phase: PHASE4
-
Clopidogrel Resistance and the Possibility of Its Affection
NCT00839345 ·Status: TEMPORARILY_NOT_AVAILABLE
-
Platelet Function Monitoring in Patients Treated With Clopidogrel at the Time of Primary Percutaneous Coronary Angioplasty
NCT00827346 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Impact of Clopidogrel Dose Adjustment According to Platelet Reactivity Monitoring in Patients With High on Treatment Platelet Reactivity Undergoing Percutaneous Coronary Intervention
NCT01505790 ·Status: COMPLETED ·Phase: PHASE3
-
Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment For Acute Coronary Syndromes Trial
NCT01959451 ·Status: COMPLETED ·Phase: PHASE4
-
Clopidogrel High Dose Evaluation for the Patient With Coronary Artery Disease in Japan
NCT01069302 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect on Blood Cells, Known as Platelets, Using Prasugrel vs Clopidogrel in Patients With the Heart Problem Acute Coronary Syndrome (ACS)
NCT00385944 ·Status: COMPLETED ·Phase: PHASE2
-
Adjunctive Cilostazol Versus High Maintenance-dose Clopidogrel According to Cytochrome 2C19 Polymorphism
NCT01012193 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacogenomics and Effective Treatment With Clopidogrel
NCT01611545 ·Status: COMPLETED
-
Efficacy and Tolerability of Clopidogrel Resinate and Clopidogrel Bisulfate in Patients With Coronary Heart Disease (CHD) or CHD Equivalents
NCT00947843 ·Status: COMPLETED ·Phase: PHASE4
-
Antiplatelet Strategy for CCS Patients Undergoing CABG
NCT06881901 ·Status: COMPLETED
-
Plasma and Platelet microRNAs in Clopidogrel Low Response Patients
NCT02447809 ·Status: UNKNOWN ·Phase: PHASE4
-
Effects of Atorvastatin Versus Pravastatin on Platelet Inhibition by Clopidogrel
NCT00405717 ·Status: COMPLETED ·Phase: PHASE4
-
Fixed-dose vs. Phenotype-based PrAsugrel Dose to MATCH Therapeutic Zone in Asians With Acute Coronary Syndrome
NCT01951001 ·Status: COMPLETED ·Phase: PHASE4
-
Genotype Guided Versus Conventional Approach in Selection of Oral P2Y12 Receptor Blocker in Chinese Patients Suffering From Acute Coronary Syndrome
NCT01994941 ·Status: COMPLETED ·Phase: PHASE4
-
Dual-antiplatelet Therapy Strategies for Elective PCI in a Real-world Setting
NCT05559918 ·Status: RECRUITING